Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Siewert

Showing results (441-450 of 461) with videos related to

Pageof 47
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasyR B Brauer, C D Heidecke, W Nathrath, et al.
The American Journal of Pathology|August 6, 1999
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutationG Keller, H Vogelsang, I Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagusP M Schneider, O Stoeltzing, J A Roth, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeksM Fromm, W E Berdel, H D Schick, et al.
Journal of Clinical Pathology|May 30, 2006
Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray studyR Langer, B H A Von Rahden, J Nahrig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imagingW A Weber, K Ott, K Becker, et al.
British Journal of Cancer|February 27, 2014
Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomasT Schmidt, L Sicic, S Blank, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trialB L D M Brücher, H J Stein, F Zimmermann, et al.
Cancer|April 12, 2006
The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomasBjörn L D M Brücher, Karen Becker, Florian Lordick, et al.
Radiology|April 28, 2007
Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survivalHinrich A Wieder, Robert Rosenberg, Florian Lordick, et al.
Pageof 47

Showing results (441-450 of 461) with videos related to

Sort By:
Pageof 47
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasyR B Brauer, C D Heidecke, W Nathrath, et al.
The American Journal of Pathology|August 6, 1999
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutationG Keller, H Vogelsang, I Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagusP M Schneider, O Stoeltzing, J A Roth, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeksM Fromm, W E Berdel, H D Schick, et al.
Journal of Clinical Pathology|May 30, 2006
Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray studyR Langer, B H A Von Rahden, J Nahrig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imagingW A Weber, K Ott, K Becker, et al.
British Journal of Cancer|February 27, 2014
Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomasT Schmidt, L Sicic, S Blank, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trialB L D M Brücher, H J Stein, F Zimmermann, et al.
Cancer|April 12, 2006
The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomasBjörn L D M Brücher, Karen Becker, Florian Lordick, et al.
Radiology|April 28, 2007
Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survivalHinrich A Wieder, Robert Rosenberg, Florian Lordick, et al.
Pageof 47